Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls
Experimental Neurobiology · 28.02.2025 · 34 (1) · 1-8
DOI: 10.5607/en25008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Neurobiology, erschienen am 28.02.2025. Verfasst von Seungyeop Baek und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, Incheon 21983, Korea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute, National Research Foundation of Korea, Yonsei University.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, Incheon 21983, Korea.
- Department of Nuclear Medicine, Korea Cancer Center Hospital, Seoul 01812, Korea.
- Department of Neurology, Korea Cancer Center Hospital, Seoul 01812, Korea.
- Division of RI-Convergence Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Korea.
- Department of Medical Biotechnology, Dongguk University, Seoul 04620, Korea.
- Department of Pharmacology, Korea University, Seoul 02841, Korea.
Förderung
- Korea Health Industry Development Institute
- National Research Foundation of Korea
- Yonsei University
Zitieren
APA
Baek, S., Lee, J. C., Byun, B. H., Park, S. Y., Ha, J. H., Lee, K. C., Yang, S. H., Lee, J. S., Hong, S., Han, G., Lim, S. M., Kim, Y., & Kim, H. Y. (2025). Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls. Experimental Neurobiology, 34(1), 1-8. https://doi.org/10.5607/en25008
Vancouver
Baek S, Lee JC, Byun BH, Park SY, Ha JH, Lee KC, et al. Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls. Experimental Neurobiology. 2025;34(1):1-8. doi:10.5607/en25008
BibTeX
@article{Baek2025,
author = {Baek, Seungyeop and Lee, Jinny Claire and Byun, Byung Hyun and Park, Su Yeon and Ha, Jeong Ho and Lee, Kyo Chul and Yang, Seung-Hoon and Lee, Jun-Seok and Hong, Seungpyo and Han, Gyoonhee and Lim, Sang Moo and Kim, YoungSoo and Kim, Hye Yun},
title = {Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls},
journal = {Experimental Neurobiology},
year = {2025},
volume = {34},
number = {1},
pages = {1--8},
doi = {10.5607/en25008}
}
EUVIMED